{
  "docId": "019de076-48c2-7315-bf77-72d2721572a4",
  "docSlug": "9ba2b11c98152a86fe4ad3555ff50f91",
  "documentTitle": "Immatics | Investor Presentation Deck | 75 slides",
  "authorId": "immatics",
  "authorName": "Immatics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 55,
  "pageCount": 75,
  "prevPage": 54,
  "nextPage": 56,
  "slideType": "product_demo",
  "function": "present_solution",
  "density": "overcrowded",
  "nDataPoints": 4,
  "notes": "The slide uses four dose-response curves to show cytotoxicity against different target copy numbers.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-48c2-7315-bf77-72d2721572a4/55",
  "deckHref": "/decks/019de076-48c2-7315-bf77-72d2721572a4",
  "deckJsonHref": "/decks/019de076-48c2-7315-bf77-72d2721572a4.json",
  "deckAnchorHref": "/decks/019de076-48c2-7315-bf77-72d2721572a4#slide-55",
  "components": [
    {
      "bbox": {
        "h": 0.25,
        "w": 0.2,
        "x": 0.3,
        "y": 0.58
      },
      "kind": "chart",
      "text": "Cytotoxicity vs IMA402 concentration for 250 PRAME CpCs",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2eea27dd-dd7d-4aa5-9863-6a8c121bfd10",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.2,
        "x": 0.04,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Cytotoxicity vs IMA402 concentration for Target-negative",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "42a69068-1a03-4d3f-a7db-3171cd99c64e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.2,
        "x": 0.04,
        "y": 0.58
      },
      "kind": "chart",
      "text": "Cytotoxicity vs IMA402 concentration for 110 PRAME CpCs",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "77a222f5-8e6b-47a6-8699-b99d545f02d2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.2,
        "x": 0.3,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Cytotoxicity vs IMA402 concentration for 50 PRAME CpCs",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f570473c-ed2e-4704-bff6-1000cd06fdde",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.38,
        "x": 0.58,
        "y": 0.28
      },
      "kind": "list",
      "text": "TCER® IMA402 induces killing of tumor cells with PRAME target copies as low as 50 CpCs. Physiological PRAME levels detected in majority of cancer tissues from patients are 100 – 1000 CpCs. Preclinical activity profile enables targeting of a broad variety of tumor indications.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3d5d4ee2-21f2-4d10-a183-a33fd694e6cb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.04,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "CpC: Target peptide copy numbers per tumor cell",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "86c6b3a2-3108-4c19-b00d-e8761d508902",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.6,
        "x": 0.04,
        "y": 0.12
      },
      "kind": "title",
      "text": "Tumor Cell Killing at Low Physiological PRAME Peptide Levels",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1acef0a1-ec79-49e2-ab6b-29e61a3f394f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.04,
        "y": 0.06
      },
      "kind": "title",
      "text": "TCER® IMA402 Targeting PRAME – Efficacy Assessment in vitro",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "964e775b-6898-4e78-adb9-5fd44a2df173",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Data-Ink Ratio",
      "slug": "data-ink-ratio",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "fbadecfa-518c-479e-939f-3e72ca2da19c",
      "evidence": "The slide effectively uses charts to display data, with a high data-ink ratio, making it easy to understand the relationship between cytotoxicity and IMA402 concentration.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}